- Trials with a EudraCT protocol (259)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (27)
259 result(s) found for: Reactivity.
Displaying page 1 of 13.
EudraCT Number: 2017-000298-35 | Sponsor Protocol Number: NL60593.028.17 | Start Date*: 2017-05-01 |
Sponsor Name:Tilburg University | ||
Full Title: Oxytocin, friendship and dealing with emotions | ||
Medical condition: There are no medical conditions or disease under investigation. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003599-21 | Sponsor Protocol Number: MEIXO-VALV-002 | Start Date*: 2015-06-27 |
Sponsor Name:Sociedad Española de Cardiología | ||
Full Title: Platelet reactivity after TAVI: A multicenter randomized clinical trial | ||
Medical condition: Study platelet reactivity in patients with Aortic Stenosis (AS) selected for TAVI and to assess the effectiviness of ticagrelor as antiplatelet monotherapy for the supression of high platelet react... | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-022461-10 | Sponsor Protocol Number: Final Version1 | Start Date*: 2011-02-08 |
Sponsor Name:Southampton University Hospitals NHS Trust | ||
Full Title: A pilot study investigating the antiplatelet effect of generic clopidogrel versus Plavix™ – is there any difference in platelet reactivity in healthy subjects? | ||
Medical condition: The intended indication for the product is for use in all patients with acute coronary syndromes and following coronary artery stenting | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-001685-42 | Sponsor Protocol Number: TAPAS2013 | Start Date*: 2013-06-21 | |||||||||||
Sponsor Name:Rigshospitalet | |||||||||||||
Full Title: Changes in coagulation and platelet reactivity in HIV-1 infected patients switching between abacavir and tenofovir containing antiretroviral regimens | |||||||||||||
Medical condition: HIV | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002987-27 | Sponsor Protocol Number: MEKOS 05 UseQ 001 | Start Date*: 2005-09-02 |
Sponsor Name:Mekos Laboratories | ||
Full Title: An open single centre evaluation of the reactivity of the T.R.U.E TestTM Quaternium-15 patch and a real use exposure in subjects known to be allergic to Quaternium-15. | ||
Medical condition: Diagnosis of Allergic Contact Dermatitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-001410-16 | Sponsor Protocol Number: 25032013 | Start Date*: 2013-07-01 |
Sponsor Name:Netherlands Heart Foundation | ||
Full Title: Effects of low-dose aspirin taken at bedtime vs. on awakening on circadian rhythm of platelet function in healthy subjects | ||
Medical condition: platelet reactivity | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000017-20 | Sponsor Protocol Number: ASS-Metamizol-DDI | Start Date*: 2018-07-17 |
Sponsor Name:Universitäts-Herzzentrum Freiburg • Bad Krozingen | ||
Full Title: Antiplatelet effect of acetylsalicylic acid in patients after cardiac surgery: Impact of dipyrone (metamizole) | ||
Medical condition: Antithrombotic therapy after surgical replacement of stenotic heart valve by a bioprosthesis or mitral valve repair | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004523-21 | Sponsor Protocol Number: V1605-201 | Start Date*: 2020-09-03 | |||||||||||
Sponsor Name:DBV Technologies S.A. | |||||||||||||
Full Title: A Phase 2 Study to Evaluate the Sensitivity and Specificity of DBV1605, a Ready to Use Atopy Patch Test for the Diagnosis of Non-Immunoglobulin E Mediated Cow’s Milk Allergy in Children. | |||||||||||||
Medical condition: Non-Immunoglobulin E Mediated Cow’s Milk Allergy | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000603-12 | Sponsor Protocol Number: 80655 | Start Date*: 2022-08-05 |
Sponsor Name:Radboud University | ||
Full Title: Oxytocin and reactivity to infant signals in mothers with postpartum depression | ||
Medical condition: We examine the effects of oxytocin on mother-infant interaction among mothers with a postpartum depression | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002227-96 | Sponsor Protocol Number: 1 | Start Date*: 2014-09-17 |
Sponsor Name:County Council of Östergötland | ||
Full Title: Inhibition of platelet aggregation after administration of three different ticagrelor loading dose formulations in patients with stable angina referred for coronary angiography | ||
Medical condition: Effect of three ticagrelor loading dose formulations on the degree and rapidity of platelet aggregation in patients with stable angina referred for coronary angiography | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004860-23 | Sponsor Protocol Number: REACTIC2019-HAC | Start Date*: 2020-05-22 |
Sponsor Name:Andres Iñiguez Romo | ||
Full Title: REACTIC-TAVI TRIAL: Platelet REACtivity according to TICagrelor dose after Trancathter Aortic Valve Implantation. A pilot study. | ||
Medical condition: Patients with severe aortic stenosis submitted for Transcatheter Aortic Valve Implantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-001209-24 | Sponsor Protocol Number: 2005DCSalcohol | Start Date*: 2005-07-08 |
Sponsor Name:University of Bristol | ||
Full Title: A double-blind, placebo controlled parallel group pilot study of the effectiveness of D-cycloserine in reducing craving during cue-exposure therapy in abstinent alcohol dependent subjects. | ||
Medical condition: Alcohol dependent patients | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2023-000029-10 | Sponsor Protocol Number: DESC-HBR | Start Date*: 2023-03-24 | |||||||||||
Sponsor Name:Azienda Ospedaliera Universitaria Gaetano Martino Messina | |||||||||||||
Full Title: De-Escalation of Antiplatelet Therapy to Evaluate Platelet Reactivity and Clinical Outcomes after Coronary Stenting in Patients at High Bleeding Risk and Recent Acute Coronary Syndrome: DESC-HBR trial | |||||||||||||
Medical condition: High bleeding risk (HBR) patients with a recent acute coronary syndrome (ACS ) who have undergone percutaneous coronary intervention (PCI) and are on double antiplatelet therapy (DAPT) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-020219-35 | Sponsor Protocol Number: | Start Date*: 2011-07-18 |
Sponsor Name:Royal Brompton & Harefield NHS Foundation Trust | ||
Full Title: Evaluating the benefit of additional platelet inhibition in acute coronary syndrome patients with high platelet reactivity undergoing PCI | ||
Medical condition: Cardiovascular disease - Acute coronary syndrome | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-003181-12 | Sponsor Protocol Number: HOTPOT1 | Start Date*: 2016-10-07 |
Sponsor Name:Royal College of Surgeons in Ireland | ||
Full Title: Can sonographic assessment of pulmonary vascular reactivity following maternal hyperoxygenation therapy predict neonatal outcome in fetuses at risk of pulmonary hypertension? | ||
Medical condition: Persistent pulmonary hypertension of the newborn (PPHN) is a relatively common condition occurring in 7/1000 births and can result in significant cardiovascular instability in the newborn. It occur... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: IE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-004959-80 | Sponsor Protocol Number: IIS14005 | Start Date*: 2017-08-01 |
Sponsor Name:Special Account For Research Funds- National and Capodistrian University of Athens | ||
Full Title: A randomized, pharmacodynamic comparison of ticagrelor 60mg bid vs prasugrel 5mg in patients with prior myocardial infarction | ||
Medical condition: In this study we aim to compare the platelet inhibition of 60mg ticagrelor bid versus 5mg prasugrel in patients with prior myocardial infarction within previous 1-3 years | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-001669-33 | Sponsor Protocol Number: tsa1 | Start Date*: 2005-12-09 |
Sponsor Name:Greater Glasgow NHS Health Board / University of Glasgow co-sponsorship | ||
Full Title: New therapeutic targets in stroke prevention: the effect of allopurinol on the cerebral vasculature of patients with subcortical stroke | ||
Medical condition: Subcortical Ischaemic Stroke | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-000744-82 | Sponsor Protocol Number: 1.1 | Start Date*: 2005-06-16 |
Sponsor Name:Medical University Vienna, Dept. of Clinical Pharmacology | ||
Full Title: Impact of rhCu/Zn SOD on inflammation-induced impairment of vascular reactivity | ||
Medical condition: 43 healthy male subjects, age 19-45 yrs. Nonsmokers | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-011538-93 | Sponsor Protocol Number: Maraviroc –switch | Start Date*: 2010-06-07 |
Sponsor Name:Imperial College London | ||
Full Title: A prospective, randomised study to access safety, changes in platelet reactivity, plasma cardiac biomarkers and metabolic parameters over 48 weeks in HIV-1 infected subjects undergoing a switch in... | ||
Medical condition: HIV | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: IE (Completed) GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-003072-39 | Sponsor Protocol Number: 41223 | Start Date*: 2012-11-27 | |||||||||||
Sponsor Name:Academic Medical Center, University of Amsterdam | |||||||||||||
Full Title: Oxytocin in PTSD: effectiveness as addition to Narrative Exposure Therapy | |||||||||||||
Medical condition: Posttraumatic stress disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.